Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the Role of CD44 in the Progression and Invasion of Chondrosarcoma.

Oncology research·2026
Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026
Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026
Same author

Surgery for thumb (trapeziometacarpal joint) osteoarthritis.

The Cochrane database of systematic reviews·2026
Same author

Intra-articular injection of autologous tolerogenic dendritic cells modifies the synovial immune landscape in rheumatoid and inflammatory arthritis.

Annals of the rheumatic diseases·2026
Same author

An <i>In Vitro</i> Investigation of 5-Aminolevulinic Acid Mediated Photodynamic Therapy in Bone Sarcoma.

Oncology research·2026
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

Cancers·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Nov 20, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.0K

Surgical Advances in Osteosarcoma.

Marcus J Brookes1, Corey D Chan1, Bence Baljer1

  • 1Translational and Clinical Research Institute, Newcastle University, Newcastle NE1 7RU, UK.

Cancers
|January 26, 2021
PubMed
Summary
This summary is machine-generated.

Recent advances in osteosarcoma (OS) surgery focus on limb preservation and improved outcomes. Innovations in imaging, navigation, and robotics offer promising future directions for treating this common childhood bone cancer.

Keywords:
osteosarcomasarcomasurgery

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.5K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.5K

Related Experiment Videos

Last Updated: Nov 20, 2025

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.0K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.5K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

10.5K

Area of Science:

  • Orthopedic Oncology
  • Surgical Innovation

Background:

  • Osteosarcoma (OS) is the most common primary bone cancer in children, often presenting with poor survival rates.
  • Traditionally treated with amputation, limb-preserving surgery introduced in the 1990s improved function but posed challenges like implant failure and limb length discrepancies.
  • OS can occur in complex anatomical regions (pelvis, spine, head, neck), increasing surgical difficulty.

Purpose of the Study:

  • To review and summarize recent advancements in surgical techniques for osteosarcoma.
  • To highlight technological innovations improving surgical planning, execution, and patient outcomes in OS treatment.

Main Methods:

  • Literature review of recent advances in osteosarcoma surgery.
  • Summary of technological developments impacting pre-operative planning, intraoperative guidance, and post-operative care.

Main Results:

  • Improved pre-operative imaging enhances surgical planning.
  • Intraoperative imaging, including fluorescent dyes, aids in achieving better surgical margins.
  • Technological developments like computer navigation, patient-specific instruments, and advanced implant designs offer opportunities to enhance patient outcomes.

Conclusions:

  • Ongoing technological advancements in osteosarcoma surgery are crucial for improving patient outcomes.
  • Future directions include targeted fluorescent dyes, robotics, and augmented reality, promising further improvements in OS treatment.